Viatris (VTRS) Operating Income Growth (5y) (2025 - 2026)

Viatris (VTRS) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.19 Bn 87.33 Bn -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn
3 Zoetis 32.52 Bn 30.58 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn
5 United Therapeutics 23.22 Bn 21.07 Bn 648.10 Mn
6 RedHill Biopharma 21.76 Bn 21.76 Bn -
7 Viatris 20.29 Bn 18.48 Bn 1.16 Bn
8 Neurocrine Biosciences 17.72 Bn 16.40 Bn 800.70 Mn
9 Elanco Animal Health 12.59 Bn 12.16 Bn 785.00 Mn
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.43%
Dec 31, 2025 26.21%
Mar 31, 2025 -77.47%